ATLASAlzamend Neuro (ALZN) earnings date: Dec 8, 2026
Alzamend Neuro (ALZN) reports earnings for the quarter ended Oct 31, 2026 on Tue, Dec 8, 2026. Analysts expect EPS of -$0.23.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ALZN
| Last price | $1.26 (+4.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.7% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Alzamend Neuro stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Alzamend Neuro reports on Dec 8, 2026. One email the day before, with ATLAS’s read on Alzamend Neuro. You can switch it off at any time.
Alert me before ALZN reportsFree to start. Creating an account takes under a minute.
Notify me when Alzamend Neuro reports
Track ALZN free Add Alzamend Neuro to a free ATLAS watchlist and see its next report date in one place.
ALZN earnings at a glance
| Next report (confirmed) | Tue, Dec 8, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Oct 31, 2026 |
| EPS estimate | -$0.23 |
| Last report | Sep 10, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +34.5% |
| Average move around a report | ±3.7% (last 4) |
| Sector | Healthcare · Biotechnology |
Alzamend Neuro earnings history: last 4 reports
Alzamend Neuro last reported on Sep 10, 2026: EPS of -$0.68 against an estimate of -$0.56 (-21.4% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 10, 2026 | -$0.56 | -$0.68 | -21.4% | Miss | +2.4% |
| Jul 22, 2026 | -$0.67 | -$0.74 | -10.5% | Miss | -4.6% |
| Mar 10, 2026 | -$0.27 | -$0.04 | +85.2% | Beat | +3.8% |
| Dec 9, 2025 | -$1.95 | -$0.30 | +84.6% | Beat | -4.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ALZN
See the fair value, the probability range and the earnings history of Alzamend Neuro on its ATLAS page.
Alzamend Neuro (ALZN) stock analysisPlans from €3.99 a month.
Alzamend Neuro earnings: frequently asked questions
When does Alzamend Neuro (ALZN) report earnings?
Alzamend Neuro is scheduled to report on Tuesday, December 8, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ALZN?
The consensus EPS estimate for the quarter ended Oct 31, 2026 is -$0.23 per share (USD). Estimates can change before the report.
How often does ALZN beat earnings estimates?
Of its last 4 reports with a recorded result, Alzamend Neuro beat the EPS estimate 2 times; the average surprise was +34.5%. Past results do not predict the next one.
How much does ALZN move around earnings?
Over its last 4 reports the stock moved an average of 3.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Alzamend Neuro beat earnings estimates last quarter?
Alzamend Neuro last reported on Sep 10, 2026: EPS of -$0.68 against an estimate of -$0.56 (-21.4% surprise), a miss.
How much does ALZN usually move in a day?
On a normal trading day the ATLAS model puts ALZN’s one-day range at about ±4.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Dec 8, 2026
Educational information, not investment advice. Disclaimer